Acquired von Willebrand’s disease (AvWD)

When screening requests for approval, the following information may be taken into account as there is some evidence for IG to be considered as an option.

RecommendationsIVIG should be considered part of multimodal therapy in emergent situations (together with desmopressin and FVIII/VWF concentrates) in patients who have not responded to other treatments.

Prescribed only in consultation with specialized hemophilia care center
Dose/Frequency of AdministrationInitial therapy: Up to 2 g/kg divided over 2 to 5 consecutive days.